基于网络药理学与实验验证探究阳和汤抑制乳腺癌的糖酵解机制OA
Mechanism of Yanghe decoction in inhibiting breast cancer via glycolysis based on network pharmacology and experimental validation
目的 探讨阳和汤(YHT)治疗三阴性乳腺癌的潜在机制.方法 ①基于TCMSP数据库筛选阳和汤活性成分,联合GeneCards获取疾病靶点,构建成分-靶点网络;采用分子对接验证核心成分与关键靶点的结合能力.②SD大鼠随机分为对照组及阳和汤低、中、高剂量组(阳和汤灌胃剂量分别为6,12,24 g/kg),每日早晚各一次,连续给药7 d,末次给药后1 h取血分离血清,将MDA-MB-231三阴性乳腺癌细胞分为对照组(10%空白血清)、YHT低剂量组(10%低剂量含药血清)、YHT中剂量组(10%中剂量含药血清)、YHT高剂量组(10%高剂量含药血清).CCK-8法检测细胞增殖活力,Transwell实验检测细胞迁移及侵袭能力,Western blot检测E-Cadherin、N-Cadherin蛋白表达水平,并检测葡萄糖消耗及乳酸生成水平.③将MDA-MB-231细胞分为对照组、YHT高剂量组和YHT高剂量+740Y-P(PI3K激活剂)组,采用Western blot检测p-PI3K、p-AKT、HIF-1α、HK2及GLUT1蛋白表达水平.结果 ①槲皮素、乙酸橙花酯和羟布宗为阳和汤核心活性成分,分子对接证实上述成分与PI3K、AKT1及HIF-1α蛋白具备较好的结合潜能.②与对照组相比,YHT低剂量组、YHT中剂量组和YHT高剂量组MDA-MB-231细胞增殖、迁移和侵袭能力均显著降低(P<0.05),E-Cadherin表达显著上调、N-Cadherin表达显著下调(P<0.05),葡萄糖消耗及乳酸生成显著减少(P<0.05);与YHT低剂量组、YHT中剂量组相比,YHT高剂量组上述指标变化更为显著(P<0.05).③与对照组相比,YHT高剂量组MDA-MB-231三阴性乳腺癌细胞中p-PI3K、p-AKT、HIF-1α、HK2及GLUT1蛋白表达水平均显著降低(P<0.001);与 YHT 高剂量组相比,YHT 高剂量+740Y-P 组 p-PI3K、p-AKT 及 HIF-1α、HK2、GLUT1 蛋白表达均显著升高(P<0.05).结论 阳和汤可抑制三阴性乳腺癌细胞的迁移、侵袭及上皮间质转化,并下调糖酵解相关蛋白的表达,其机制可能与抑制PI3K/AKT/HIF-1α信号轴的激活有关.
Objective To investigate the potential mechanism of Yanghe decoction(YHT)in the treatment of triple-negative breast cancer.Methods ①Active components of YHT were screened using the TCMSP database,and disease targets were obtained from the GeneCards database.A component-target network was subsequently constructed,followed by molecular docking to validate the binding affinity between core components and key targets.②Sprague-Dawley(SD)rats were randomly divided into a control group and low-,medium-,and high-dose Yanghe Tang groups,which received intragastric administration of YHT at doses of 6,12,24 g/kg,respectively,twice daily(morning and evening)for 7 consecutive days.Blood samples were collected 1 h after the final administration,and sera were separated to obtain the corresponding medicated sera.MDA-MB-231 triple-negative breast cancer cells were then assigned to a control group(receiving 10%blank serum),and YHT low-,medium-,and high-dose groups(receiving 10%low-,medium-,and high-dose medicated serum,respectively).Cell proliferation viability was assessed by CCK-8 assay;cell migration and invasion were evaluated by Transwell assay;protein expression levels of E-Cadherin and N-Cadherin were detected by western blot;and glucose con-sumption and lactate production levels were also measured.③MDA-MB-231 cells were divided into a control group,a YHT high-dose group and a YHT high-dose+740Y-P(PI3K activator)group.Protein expression levels of p-PI3K,p-AKT,HIF-1α,HK2,and GLUT1 were examined by Western blot.Results ①Quercetin,neryl acetate,and oxyphenbutazone were identified as the core active compo-nents of YHT.Molecular docking demonstrated that these components exhibit favorable binding affinities for PI3K,AKT1,and HIF-1α proteins.②Compared with control group,the proliferation,migration,and invasion abilities of MDA-MB-231 triple-negative breast cancer cells significantly reduced in YHT low-,medium-,and high-dose groups(P<0.05);E-Cadherin expression was significantly up-regulated while N-Cadherin expression was significantly down-regulated(P<0.05);and glucose consumption and lactate production were markedly decreased(P<0.05).Moreover,compared with YHT low-and medium-dose groups,the above indicators in YHT high-dose group exhibited more pronounced changes(P<0.05).③Compared with control group,the protein expression levels of p-PI3K,p-AKT,HIF-1α,HK2,and GLUT1 in high-dose YHT group significantly decreased(all P<0.001).Compared with YHT high-dose group,protein levels of p-PI3K,p-AKT,HIF-1α,HK2,and GLUT1 significantly increased in YHT high-dose+740Y-P group(P<0.05).Conclusion YHT suppresses the migration,invasion,and epithelial-mesenchymal transition of triple-negative breast cancer cells and reduces the expression of glycolysis-related proteins,which may involve the inhibition of the PI3K/AKT/HIF-1α signaling axis.
孙艾琳;李济宇;徐轶尔;孙贵才;范春香
复旦大学附属浦东医院中医科,上海 201399复旦大学附属浦东医院中医科,上海 201399哈药集团技术中心南昌大学第一附属医院骨科复旦大学附属浦东医院中医科,上海 201399
医药卫生
阳和汤三阴性乳腺癌网络药理学分子对接上皮-间质转化细胞生物学功能PI3K/AKT信号通路糖酵解
Yanghe decoctiontriple-negative breast cancernetwork pharmacologymolecular dockingepithelial-mesenchymal transitioncell biological functionPI3K/AKT signaling pathwayglycolysis
《山西医科大学学报》 2026 (8)
845-856,12
上海市浦东新区名中医工作室建设项目(PDZY-2025-0720)上海市浦东新区名中医继承人培养项目(PDZY-2025-0949)复旦大学附属浦东医院引进人才项目(YJYJRC202305)国家自然科学基金项目(82260870)
评论